FundedIQ
Biotechnology

Lucira Health: Funding, Investors & Team (Oct 2026)

Lucira Health is a medical technology company focused on the development and commercialization of transformative and innovative infectious disease test kits. Lucira has developed a testing platform that produces centralized-laboratory-accurate molecular testing in a single-use and consumer-friendly test kit that is powered by two AA batteries and fits in the palm of a hand. Lucira designed its test kits to provide accurate, reliable and on-the-spot molecular test results anywhere and at any time. The LUCIRA COVID-19 All-In-One Test Kit is designed to provide a clinically relevant COVID-19 result within 30 minutes from sample collection.

www.lucirahealth.com LinkedIn Emeryville, United States 101-250 employees
Total raised
$80.0M
Rounds
1
Latest
Post-IPO Debt
Feb 2022

Lucira Health has raised $80.0M across 1 funding round on record, the most recent a Post-IPO Debt of $80.0M announced in Feb 2022.

That round is above the $8.4M median round size for Biotechnology companies tracked on FundedIQ over the last two years.

Lucira Health Company Profile and Key Stats

Total funding raised
$80.0M
across 1 round on record
Funding rounds on record
1
Latest funding round
Post-IPO Debt
$80.0M in Feb 2022
Employees
101-250
reported band
Headquarters
Emeryville, United States

Latest funding round on record: Feb 2022.

Lucira Health Funding Rounds

Date
Round
Amount
Post-IPO Debt
$80.0M

Lucira Health Founders and Leadership Team

Name
Role
Contact
Erik Engelson
CEO
Locked

Contact details for the Lucira Health team: 1 of 1 has an email address on file.

Start 14-day free trial →

Lucira Health Funding Compared to Other Biotechnology Startups

Segment
Companies
Median round
4,185
$8.4M
30,319
$7.7M

Lucira Health's latest round of $80.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.

Funded Startups Like Lucira Health in Biotechnology and Emeryville

Companies Similar to Lucira Health

Prolific Machines is a biotech company located in San Francisco, California, that was established in 2020. It…

Series B $50.0M

Altay Therapeutics is a biotech company focused on finding and discovering small molecule therapies for…

Series A $37.0M
Series B $150M

Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…

Undisclosed round $94.0M

Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…

Series B $9.5M

Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…

Series B $33.0M

Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…

Undisclosed round —

Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.

Series A $15.0M

Serán is a contract development and manufacturing organization providing a comprehensive suite of…

Private Equity —

Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…

Series D $250M

Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…

Series E $311M

Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…

Undisclosed round $8.5M

Lucira Health Funding FAQs

What does Lucira Health do?

Lucira Health is a medical technology company focused on the development and commercialization of transformative and innovative infectious disease test kits. Lucira has developed a testing platform that produces centralized-laboratory-accurate molecular testing in a single-use and consumer-friendly test kit that is powered by two AA batteries and fits in the palm of a hand. Lucira designed its test kits to provide accurate, reliable and on-the-spot molecular test results anywhere and at any time. The LUCIRA COVID-19 All-In-One Test Kit is designed to provide a clinically relevant COVID-19 result within 30 minutes from sample collection.

How much funding has Lucira Health raised?

Lucira Health has raised $80.0M across 1 round on record. The most recent is a Post-IPO Debt of $80.0M announced in Feb 2022.

When did Lucira Health last raise funding?

Lucira Health's most recent funding round on record is a Post-IPO Debt of $80.0M, announced in Feb 2022.

Who is the CEO of Lucira Health?

Erik Engelson is listed as CEO at Lucira Health.

Where is Lucira Health headquartered?

Lucira Health is based in Emeryville, California, United States.

How many employees does Lucira Health have?

Lucira Health is in the 101-250 employee band.

How does Lucira Health's funding compare to other Biotechnology startups?

Lucira Health's latest round of $80.0M is above the $8.4M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.

About FundedIQ's Lucira Health Funding Data

FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.

Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Lucira Health is left off this page rather than filled in.

14-day free trial · Cancel anytime

Know who just raised. Then know who to reach.

Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.

Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.